Intracellular metallothioneins (MT1 and MT2) that regulates zinc metabolism was found highly enriched in dysfunctional CD8+ tumor-infiltrating T cells (TILs) at the same time as targeted deletion of metallothioneins reversed T cell dysfunction and controlled tumor growth without reduction of expression of co-inhibitory receptors (20). The gene discussed is CD8A; the disease is neoplasm.